Accumulating evidence suggests that dysregulation of brain insulin receptor (IR) signaling is associated with the pathogenesis of Alzheimer’s disease [11, 15, 28, 57]. The gene discussed is INSR; the disease is early-onset autosomal dominant Alzheimer disease.